PIMSTONE SIMON N. (CEO) sold 3.9% of their position (10.39K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $98.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/24/2019ACC: 0001209191-19-050588
DirectorOfficer· CEO
Since Sep 2019
-10.39K
Net shares
Net seller
$98.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.39K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−10.39K
Price / share
$9.51
Trade value
$98.86K
% of position
3.9%
9/20/2019
268.52K→258.12K
Total
Net shares
−10.39K
Net value
-$98.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/20/2019 | S · Sale | −10.39K | $9.51 | $98.86K | 3.9% | 268.52K | 258.12K |
| Total | −10.39K | -$98.86K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Shares
IndirectShares owned16.46K
Total
16.46K indirect16.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 16.46K | Indirect |
| Total | 16.46K | 16.46K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported